Important Insulin Delivery Devices Safety Reminder
Eli Lilly Canada Inc.
3650 Danforth Avenue
Toronto, ON M1N 2E8
Canada
December 11, 2001
Important New Safety Reminder Regarding the HumaPen® Ergo
Dear HumaPen® Ergo Customer,
Eli Lilly Canada Inc., following discussions with Health Canada, would like to remind you of important safety information regarding the HumaPen® Ergo and its proper use to ensure delivery of the desired insulin dose.
During the past year, a new insulin Clear Cartridge Holder was introduced for the HumaPen® Ergo. (Older HumaPen® Ergo cartridge holders were made of a nontransparent blue plastic and susceptible to breakage). This new Clear Cartridge Holder was designed to improve the functionality and strength of the HumaPen® Ergo.
-
If you are currently using the HumaPen® Ergo and have not upgraded to the new Clear Cartridge Holder please read the following information carefully. In order to extend the life of your HumaPen® Ergo, you should REPLACE your existing cartridge holder with the new Clear Cartridge Holder AS SOON AS POSSIBLE. The new Clear Cartridge Holder offers significant advantages
-
More Robust Product: The new Clear Cartridge Holder is made from a high molecular weight plastic and has a more robust design to prevent breakage.
-
Increased Visibility: The visibility has been increased by 73% to allow patients to better see the insulin they are taking and the amount remaining in the cartridge.
-
Better Cap Fit: The new Clear Cartridge Holder design creates an improved snug fit for the cap and allows for easier portability.
-
More Definite Fit & Twist Lock-In: The new Clear Cartridge Holder twist-locks in place with a more definite fit. The cartridge holder must be locked in place to ensure the proper functioning of the pen and precise delivery of the desired dose of insulin. This can be checked by priming your HumaPen® Ergo prior to each injection, as directed in step 7 of the HumaPen® Ergo user manual.
-
Please visit your local pharmacy to obtain your FREE Clear Cartridge Holder Upgrade Kit. If you have any questions or have not been able to obtain an Upgrade Kit through your pharmacy, please call the Lilly Customer Response Centre at 1-888-545-5972.
-
Until you have replaced your old cartridge holder with the new Clear Cartridge Holder, please check for broken or damaged parts before every injection. Do not use the pen if any part appears broken or damaged. Please refer to the "Important Notes" section of the HumaPen® Ergo instruction manual, which you received with your HumaPen® Ergo or Clear Cartridge Holder Kit. If you would like an additional copy of the HumaPen® Ergo instruction manual please contact the Lilly Customer Response Centre at 1-888-545-5972.
-
The proper way to deliver insulin with the HumaPen® Ergo is to depress the plunger after the correct dose has been dialed and the pen has been checked for insulin flow. The HumaPen® Ergo does not eject insulin if you dial the dosage knob backwards. This feature prevents the wastage of insulin when correcting the insulin dose. Please consult steps 8 - 10 of the HumaPen® Ergo instruction manual for more details. Should you have any questions regarding the proper use of the HumaPen® Ergo please contact the Lilly Customer Response Centre at 1-888-545-5972.
Additional Important Safety Information
Regarding Insulin Delivery Devices:
-
Insulin Pen instruction manuals should always be read carefully before the device is used. Failure to follow the instructions may result in an inaccurate insulin dose.
-
Insulin Pens should not be stored with the needle-tip attached as this may cause air bubbles to enter the insulin cartridge. A new needle-tip should be used with each injection. This will help ensure sterility and prevent leakage, reentry of air, and potential needle clogs. The HumaPen® Ergo is suitable for use with Becton-Dickinson brand needle tips.
-
Before an injection, users should check that the pen is delivering insulin by testing it according to the instructions in the insulin pen manual.
We hope you find this information useful. The proper use of any insulin delivery device is critical to ensure proper blood glucose control.
At Eli Lilly Canada Inc., we are always looking for ways to improve our products to ensure they meet your needs. Should you have any questions about this information or any other question, please do not hesitate to contact the Lilly Customer Response Centre at 1-888-545-5972.
Sincerely,
original signed by
Joerg Rustige, MD
Vice President, Research and Development
Eli Lilly Canada Inc.
Any suspected adverse reactions can also be reported to:
Marketed Health Products Directorate
HEALTH CANADA
Address Locator: 3002C
OTTAWA, Ontario, K1A 0K9
Tel: The Medical Devices Hotline 1-800-267-9675
[Text of letter ends]